Cordis Corporation SMART FLEX 8x60 BIL, 80cm The S.M.A.R.T. Flex Biliary Stent System is indicated for use in the palliation of malignant strictures in the biliary tree. Recall
Hazard assessment based on recall description.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
SMART FLEX 8x60 BIL, 80cm The S.M.A.R.T. Flex Biliary Stent System is indicated for use in the palliation of malignant strictures in the biliary tree.
Brand
Cordis Corporation
Lot Codes / Batch Numbers
Product Code: SF08060SB, Lot No. 266523
Products Sold
Product Code: SF08060SB; Lot No. 266523
Cordis Corporation is recalling SMART FLEX 8x60 BIL, 80cm The S.M.A.R.T. Flex Biliary Stent System is indicated for use in the pall due to There is a potential for distal tip dislodgement or separation.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
There is a potential for distal tip dislodgement or separation.
Recommended Action
Per FDA guidance
The firm, Cordis, sent an "Urgent MEDICAL DEVICE RECALL" letter dated 10/1/2021 to its consignees/customers: In the US: The letter and Acknowledgement Form was sent to the following two (2) individuals in each account: Materials Director, and Risk Manager. The delivered letter will be followed up as necessary by phone, until signed Acknowledgement is received, or best effort attempt has occurred. For Affiliate countries: A copy of the letter sent to the affiliates by email. Reconciliation within the country will be performed by the affiliate. A summary statement that the notification is completed is requested of the affiliate. Consignees are asked to do the following: 1) Read the Urgent Medical Device Recall letter. 2) Immediately check your inventory to confirm that you do not have any units from the affected lots in your possession. If you discover that you do have units from the affected lots in your possession, identify and set aside any units from the identified lots in a manner that ensures the affected product will not be used. Check all storage and usage locations. 3) Review, complete, sign and return the enclosed Acknowledgement Form directly to Cordis at the fax number on the form or email to: GMB-CordisFieldAction@cardinalhealth.com 4) Return any affected product to the address listed on the form, with reference to your Customer Number, which is listed on the form. 5) Share this letter with others in your facility who need to be made aware of this recall and with any other facility that may have been sent the affected units of product from your facility. If any units of the affected lots are found to be at the other facility, please arrange the return of the units. Maintain awareness of this notice until all affected product has been returned to Cordis. 6) Keep a copy of this notice with the affected product. For any health care professional with medical concerns, please contact Cordis to speak to a clinician at 1-800-327-7714 Option 1, Monday through F
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
CA, FL, IN, LA, OH, OK, TX
Page updated: Jan 10, 2026